4//SEC Filing
Carter Charles Ross 4
Accession 0001213900-24-057868
CIK 0001870404other
Filed
Jun 30, 8:00 PM ET
Accepted
Jul 1, 4:01 PM ET
Size
5.7 KB
Accession
0001213900-24-057868
Insider Transaction Report
Form 4
Carter Charles Ross
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-06-28+100,000→ 100,000 totalExercise: $0.30Exp: 2034-06-28→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]All of the shares underlying this option will vest on the date of the acceptance of an Investigational New Drug application by the U.S. Food and Drug Administration, subject to the Reporting Person's continued service on such vesting date.
Documents
Issuer
CERO THERAPEUTICS HOLDINGS, INC.
CIK 0001870404
Entity typeother
Related Parties
1- filerCIK 0001779359
Filing Metadata
- Form type
- 4
- Filed
- Jun 30, 8:00 PM ET
- Accepted
- Jul 1, 4:01 PM ET
- Size
- 5.7 KB